These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22712811)

  • 1. Transient ischemic attack caused by delayed orthostatic hypotension in an elderly hypertensive patient.
    Galizia G; Convertino G; Testa G; Langellotto A; Rengo F; Abete P
    Geriatr Gerontol Int; 2012 Jul; 12(3):565-7. PubMed ID: 22712811
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA takes slow road toward withdrawal of drug approved with fast-track process.
    Mitka M
    JAMA; 2011 Mar; 305(10):982, 984. PubMed ID: 21386071
    [No Abstract]   [Full Text] [Related]  

  • 3. A new hope in the nightmare of diabetic orthostatic hypotension: the midodrine-fludrocortisone association.
    Andreelli F; Plotton I; Thivolet C; Riou JP
    Diabetes Obes Metab; 1999 Sep; 1(5):297-8. PubMed ID: 11225642
    [No Abstract]   [Full Text] [Related]  

  • 4. The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale.
    Kaufmann H; Malamut R; Norcliffe-Kaufmann L; Rosa K; Freeman R
    Clin Auton Res; 2012 Apr; 22(2):79-90. PubMed ID: 22045363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midodrine prescribed to improve recurrent post-spaceflight orthostatic hypotension.
    Platts SH; Ziegler MG; Waters WW; Mitchell BM; Meck JV
    Aviat Space Environ Med; 2004 Jun; 75(6):554-6. PubMed ID: 15198285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of midodrine for neurogenic orthostatic hypotension.
    Berlin I
    JAMA; 1997 Aug; 278(5):388. PubMed ID: 9244329
    [No Abstract]   [Full Text] [Related]  

  • 7. Midodrine: a selective alpha-adrenergic agonist for orthostatic hypotension and dialysis hypotension.
    Cruz DN
    Expert Opin Pharmacother; 2000 May; 1(4):835-40. PubMed ID: 11249519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Midodrine Hydrochloride for Prevention of Orthostatic Hypotension during Early Mobilization after Hip Arthroplasty: A Randomized, Double-blind, Placebo-controlled Trial.
    Jans Ø; Mehlsen J; Kjærsgaard-Andersen P; Husted H; Solgaard S; Josiassen J; Lunn TH; Kehlet H
    Anesthesiology; 2015 Dec; 123(6):1292-300. PubMed ID: 26492477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midodrine for orthostatic hypotension.
    Med Lett Drugs Ther; 1997 Jun; 39(1003):59-60. PubMed ID: 9205432
    [No Abstract]   [Full Text] [Related]  

  • 10. Adult-onset idiopathic isolated central hypothyroidism: a case report and literature review.
    Tang C; Yu R
    Endocrinol Nutr; 2015 Jan; 62(1):49-50. PubMed ID: 25467633
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiopathic orthostatic hypotension, midodrine, and anaesthesia.
    Osborne PJ; Lee LW
    Can J Anaesth; 1991 May; 38(4 Pt 1):499-501. PubMed ID: 1712258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.
    Low PA; Gilden JL; Freeman R; Sheng KN; McElligott MA
    JAMA; 1997 Apr; 277(13):1046-51. PubMed ID: 9091692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midodrine hydrochloride and the treatment of orthostatic hypotension in tetraplegia: two cases and a review of the literature.
    Barber DB; Rogers SJ; Fredrickson MD; Able AC
    Spinal Cord; 2000 Feb; 38(2):109-11. PubMed ID: 10762185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midodrine marketed for orthostatic hypotension.
    Am J Health Syst Pharm; 1996 Nov; 53(21):2552, 2556. PubMed ID: 8913378
    [No Abstract]   [Full Text] [Related]  

  • 15. Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders.
    McTavish D; Goa KL
    Drugs; 1989 Nov; 38(5):757-77. PubMed ID: 2480881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midodrine for severe orthostatic hypotension.
    Drug Ther Bull; 2016 May; 54(5):54-6. PubMed ID: 27173783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of midodrine for neurogenic orthostatic hypotension. Reply.
    Low PA; Gilden JL; Freeman R; Sheng KN; McElligott MA
    JAMA; 1997 Aug; 278(5):388. PubMed ID: 11536812
    [No Abstract]   [Full Text] [Related]  

  • 18. Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.
    Goodman BP; Gupta F
    Clin Auton Res; 2017 Jul; 27(Suppl 1):21-23. PubMed ID: 28631222
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged supine hypertension due to midodrine use in an orthostatic hypotensive child.
    Olgar S; Omeroglu RE
    Pediatr Cardiol; 2007; 28(4):309-10. PubMed ID: 17530320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of orthostatic hypotension with midodrine and octreotide.
    Hoeldtke RD; Horvath GG; Bryner KD; Hobbs GR
    J Clin Endocrinol Metab; 1998 Feb; 83(2):339-43. PubMed ID: 9467537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.